1. LBA30ERA 223: A phase III trial of radium-223 (Ra-223) in combination with abiraterone acetate and prednisone/prednisolone for the treatment of asymptomatic or mildly symptomatic chemotherapy-naïve patients (pts) with bone-predominant metastatic castration-resistant prostate cancer (mCRPC). (23rd October 2018) Authors: Smith, M R; Parker, C C; Saad, F; Miller, K; Tombal, B; Ng, Q S; Bögemann, M; Matveev, V; Piulats, J M; Zucca, L E; Heidenreich, A; Kakehi, Y; Zhang, A; Krissel, H; Shen, J; Wagner, V; Higano, C Journal: Annals of oncology Issue: Volume 29(2018)Supplement 8 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗